使用定量高通量查平台来识别分子标和化合物作为对子宫内膜异位症的重新定位候选者
Molly L Churchill1, Sarah J Holdsworth-Carson1,2, Karla J Cowley3
1Gynaecology Research Centre, Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Parkville, VIC 3052, Australia.
Biomolecules
|June 28, 2023
概括
研究人员选了3517种化合物,以寻找新的子宫内膜异位症治疗方法. 他们发现了23种针对雌激素驱动细胞生长的新型化合物,为这种慢性疾病提供了更好的治疗方法的希望.
科学领域:
- 生殖生物学 生殖生物学
- 药理学 药理学 是一个学科.
- 泌尿生殖系统医学
背景情况:
- 子宫内膜异位症是一种依赖于雌激素的慢性炎症性疾病,影响到生育年龄的女性和有子宫的不同性别人士的11.4%.
- 目前的治疗方法缺乏长期治疗方法,迫切需要发现新的,安全和有效的治疗方法.
- 确定新的治疗点对于改善患者的治疗结果和了解疾病进展至关重要.
研究的目的:
- 对临床批准的化合物进行高通量查,以确定对子宫内膜异位症的新疗法.
- 研究涉及子宫内膜异位症病理生理学的分子标和信号通路.
- 为了确定大规模的复合查对子宫内膜异位症药物发现的可行性.
主要方法:
- 对3517种经过临床批准的药物进行定量高通量化合物选.
- 利用患者衍生不朽化的人体子宫内膜层细胞系.
- 开发并优化了查协议,以识别抑制雌激素刺激细胞生长的化合物.
主要成果:
- 确定了23种新型化合物,这些化合物干扰着雌激素刺激的子宫内膜细胞生长.
- 描述了分子标和in silico细胞信号通路,包括神经活性联体受体相互作用,代谢通路和与癌症相关的通路.
- 证明了对子宫内膜异位症治疗药物的大规模化合物查的可行性.
结论:
- 这项研究成功地确定了具有治疗子宫内膜异位症治疗潜力的新型化合物.
- 这些发现强调了高通量查在复杂疾病的药物发现中的有用性.
- 对已识别的分子点进行进一步的研究将阐明子宫内膜异位症的机制,并为未来的治疗策略提供信息.
相关概念视频
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...